High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) study
To access this article, please choose from the options below
PII: S0002-8703(03)00654-9
doi:10.1016/j.ahj.2003.09.013
© 2004 Mosby, Inc. All rights reserved.
